Health
Remdesivir, given to half of hospitalized covid patients in U.S., is big win for Gilead — boosted by taxpayers – News-Medical.Net
It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced “highly…
It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced “highly significant” news about a drug called remdesivir.
That was surprising because the antiviral drug, owned by Gilead Sciences and developed with investment from the federal government, had languished for years with no apparent commercial use. It had struck out as a treatment for hepatitis C and Ebola.
But early in 2020, when the first global…
-
General12 hours agoWondering about winter | The Spectator Australia
-
Noosa News20 hours agoOz Lotto’s $70 million jackpot won by Queensland syndicate – but not all of the winners know yet
-
Noosa News18 hours agoMan charged with murder after wife found dead in suspicious house fire near Toowoomba
-
Noosa News17 hours agoCameron Hunt, 45, charged with murder after body of his wife Louise Hunt found inside their Geham home just outside Toowoomba